Table 2.
Clinical courses.
| Fibrosis | Non-Fibrosis | p-Value € | |
|---|---|---|---|
| (N = 43) | (N = 55) | ||
| Length of hospital stay, days (mean ± SD) | 15.1 ± 8.3 | 12.7 ± 16.0 | 0.372 |
| ICU admission, yes (N, %) | 19 (44.2%) | 10 (18.2%) | 0.005 |
| Oxygen support, max (N, %) * | 0.009 | ||
| Support was not needed | 4 (9.3) | 13 (23.6) | |
| NP or simple mask | 15 (34.9) | 29 (52.7) | |
| Reservoir bag or HFNC | 22 (51.2) | 11 (20.0) | |
| Mechanical ventilation | 2 (4.7) | 2 (3.7) | |
| Medication, yes (N, %) | |||
| Antiviral agents | 37 (86.0) | 33 (60.0) | 0.005 |
| Monoclonal antibodies | 9 (20.9) | 8 (14.5) | 0.407 |
| Steroids | 41 (95.3) | 37 (69.8) | 0.001 |
| Antibacterial agents | 31 (73.8) | 32 (60.4) | 0.169 |
HFNC: high-flow nasal cannula; ECMO: extracorporeal membrane oxygenation; KL-6: Krebs von den Lungen-6; NP: nasal prong. Values are presented as a number (%), mean (standard deviation (SD)), or median (interquartile range). € Tested by chi-squared test for categorical variables and by t-test for continuous ones. * Tested by Fisher’s exact test.